Literature DB >> 28350945

Intervertebral Disk Degeneration and Repair.

James Dowdell1, Mark Erwin2, Theodoe Choma3, Alexander Vaccaro4, James Iatridis1, Samuel K Cho1.   

Abstract

Intervertebral disk (IVD) degeneration is a natural progression of the aging process. Degenerative disk disease (DDD) is a pathologic condition associated with IVD that has been associated with chronic back pain. There are a variety of different mechanisms of DDD (genetic, mechanical, exposure). Each of these pathways leads to a final common result of unbalancing the anabolic and catabolic environment of the extracellular matrix in favor of catabolism. Attempts have been made to gain an understanding of the process of IVD degeneration with in Vitro studies. These models help our understanding of the disease process, but are limited as they do not come close to replicating the complexities that exist with an in Vivo model. Animal models have been developed to help us gain further understanding of the degenerative cascade of IVD degeneration In Vivo and test experimental treatment modalities to either prevent or reverse the process of DDD. Many modalities for treatment of DDD have been developed including therapeutic protein injections, stem cell injections, gene therapy, and tissue engineering. These interventions have had promising outcomes in animal models. Several of these modalities have been attempted in human trials, with early outcomes having promising results. Further, increasing our understanding of the degenerative process is essential to the development of new therapeutic interventions and the optimization of existing treatment protocols. Despite limited data, biological therapies are a promising treatment modality for DDD that could impact our future management of low back pain.
Copyright © 2016 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Biologics; Disk degeneration; Disk repair; Gene therapy; Injectables; Intervertebral disk; Spine; Stem cells; Tissue engineering

Mesh:

Year:  2017        PMID: 28350945      PMCID: PMC5585783          DOI: 10.1093/neuros/nyw078

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  83 in total

1.  Disc degeneration of the lumbar spine in relation to overweight.

Authors:  M Liuke; S Solovieva; A Lamminen; K Luoma; P Leino-Arjas; R Luukkonen; H Riihimäki
Journal:  Int J Obes (Lond)       Date:  2005-08       Impact factor: 5.095

Review 2.  What is intervertebral disc degeneration, and what causes it?

Authors:  Michael A Adams; Peter J Roughley
Journal:  Spine (Phila Pa 1976)       Date:  2006-08-15       Impact factor: 3.468

3.  The long-term effects of physical loading and exercise lifestyles on back-related symptoms, disability, and spinal pathology among men.

Authors:  T Videman; S Sarna; M C Battié; S Koskinen; K Gill; H Paananen; L Gibbons
Journal:  Spine (Phila Pa 1976)       Date:  1995-03-15       Impact factor: 3.468

4.  The role of cyclooxygenase-2 in lumbar disc herniation.

Authors:  Hiroshi Miyamoto; Ryuichi Saura; Minoru Doita; Masahiro Kurosaka; Kosaku Mizuno
Journal:  Spine (Phila Pa 1976)       Date:  2002-11-15       Impact factor: 3.468

5.  Clinical experience in cell-based therapeutics: intervention and outcome.

Authors:  Hans Joerg Meisel; Timothy Ganey; William C Hutton; Jeanette Libera; Yvonne Minkus; Olivera Alasevic
Journal:  Eur Spine J       Date:  2006-07-19       Impact factor: 3.134

6.  Stimulation of mature canine intervertebral disc by growth factors.

Authors:  J P Thompson; T R Oegema; D S Bradford
Journal:  Spine (Phila Pa 1976)       Date:  1991-03       Impact factor: 3.468

7.  Experimental disc degeneration due to endplate injury.

Authors:  Sten Holm; Allison Kaigle Holm; Lars Ekström; Abbas Karladani; Tommy Hansson
Journal:  J Spinal Disord Tech       Date:  2004-02

8.  Increased cell senescence is associated with decreased cell proliferation in vivo in the degenerating human annulus.

Authors:  Helen E Gruber; Jane A Ingram; Daniel E Davis; Edward N Hanley
Journal:  Spine J       Date:  2008-04-25       Impact factor: 4.166

9.  Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk.

Authors:  Amit Agrawal; Asha Guttapalli; Srinivas Narayan; Todd J Albert; Irving M Shapiro; Makarand V Risbud
Journal:  Am J Physiol Cell Physiol       Date:  2007-04-18       Impact factor: 4.249

10.  Effect of small interference RNA (siRNA) for ADAMTS5 on intervertebral disc degeneration in the rabbit anular needle-puncture model.

Authors:  Shoji Seki; Yumiko Asanuma-Abe; Koichi Masuda; Yoshiharu Kawaguchi; Kunihiro Asanuma; Carol Muehleman; Akiko Iwai; Tomoatsu Kimura
Journal:  Arthritis Res Ther       Date:  2009-11-04       Impact factor: 5.156

View more
  96 in total

Review 1.  Stem Cell Therapies for Treatment of Discogenic Low Back Pain: a Comprehensive Review.

Authors:  Ivan Urits; Alexander Capuco; Medha Sharma; Alan D Kaye; Omar Viswanath; Elyse M Cornett; Vwaire Orhurhu
Journal:  Curr Pain Headache Rep       Date:  2019-07-29

2.  SKI knockdown suppresses apoptosis and extracellular matrix degradation of nucleus pulposus cells via inhibition of the Wnt/β-catenin pathway and ameliorates disc degeneration.

Authors:  Zuo-Long Wu; Ya-Jun Chen; Guang-Zhi Zhang; Qi-Qi Xie; Ke-Ping Wang; Xin Yang; Tai-Cong Liu; Zhi-Qiang Wang; Guang-Hai Zhao; Hai-Hong Zhang
Journal:  Apoptosis       Date:  2022-02-11       Impact factor: 4.677

3.  Trends and patterns of cervical degenerative disc disease: an analysis of magnetic resonance imaging of 1300 symptomatic patients.

Authors:  Mohamed Kamal Mesregah; Michael Repajic; Paul Mgbam; Zoe Fresquez; Jeffrey C Wang; Zorica Buser
Journal:  Eur Spine J       Date:  2022-08-06       Impact factor: 2.721

4.  Graded-Three-Dimensional Cell-Encapsulating Hydrogel as a Potential Biologic Scaffold for Disc Tissue Engineering.

Authors:  Zhixiang Li; Yiwen Zhang; Yupeng Zhao; Xubin Gao; Zhonglian Zhu; Yingji Mao; Taibao Qian
Journal:  Tissue Eng Regen Med       Date:  2022-08-13       Impact factor: 4.451

5.  Association of lumbar vertebral bone marrow and paraspinal muscle fat composition with intervertebral disc degeneration: 3T quantitative MRI findings from the population-based KORA study.

Authors:  Matthias Jung; Susanne Rospleszcz; Maximilian T Löffler; Sven S Walter; Elke Maurer; Pia M Jungmann; Annette Peters; Johanna Nattenmüller; Christopher L Schlett; Fabian Bamberg; Lena S Kiefer; Thierno D Diallo
Journal:  Eur Radiol       Date:  2022-10-14       Impact factor: 7.034

6.  Orientin downregulating oxidative stress-mediated endoplasmic reticulum stress and mitochondrial dysfunction through AMPK/SIRT1 pathway in rat nucleus pulposus cells in vitro and attenuated intervertebral disc degeneration in vivo.

Authors:  Zhao Zhang; Jingtao Wu; Cheng Teng; Jinquan Wang; Jiapei Yu; Chen Jin; Libo Wang; Long Wu; Zhen Lin; Ziping Yu; Zhongke Lin
Journal:  Apoptosis       Date:  2022-09-20       Impact factor: 5.561

Review 7.  Innervation of the Human Intervertebral Disc: A Scoping Review.

Authors:  Adam M R Groh; Dale E Fournier; Michele C Battié; Cheryle A Séguin
Journal:  Pain Med       Date:  2021-06-04       Impact factor: 3.750

8.  Neuropeptide Y prevents nucleus pulposus cells from cell apoptosis and IL‑1β‑induced extracellular matrix degradation.

Authors:  Kaiqiang Sun; Jian Zhu; Jingchuan Sun; Xiaofei Sun; Le Huan; Bin Zhang; Feng Lin; Bing Zheng; Jialin Jiang; Xi Luo; Ximing Xu; Jiangang Shi
Journal:  Cell Cycle       Date:  2021-05-08       Impact factor: 4.534

9.  A comparative study of mesenchymal stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease.

Authors:  Ajay Matta; Muhammad Zia Karim; Hoda Gerami; Bettina Benigno; W Mark Erwin
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

Review 10.  [Research progress on the role of adipokines in intervertebral disc degeneration].

Authors:  Chaoyang Gong; Guanghai Zhao; Gao Xiang; Kaixin Liu; Haihong Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.